Neoplasm of Uncertain Malignant Potential

general

A neoplasm displaying morphologic, phenotypic, or genotypic characteristics that are clearly not benign but do not permit the establishment of a definitive diagnosis of malignancy. Such neoplasms may or may not eventually have a more aggressive clinical course. Representative examples include lymphoproliferations of uncertain malignant potential (e.g., lymphomatoid granulomatosis and lymphomatoid papulosis), borderline ovarian epithelial neoplasms (e.g., borderline ovarian endometrioid tumor a

67

Centers

59

Active Trials

Cancer Funding

Specific Cancer Types(1)

NameCenters
Borderline Peritoneal Serous Tumor

Top Centers for Neoplasm of Uncertain Malignant Potential(67)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
53.4
2
NCI Comprehensive
Active Research Program
53.4
3
NCI Comprehensive
Active Research Program
53.4
4
NCI Comprehensive
Active Research Program
53.4
5
NCI Comprehensive
Active Research Program
53.4
6
NCI Comprehensive
Active Research Program
53.4
7
NCI Comprehensive
Active Research Program
53.4
8
NCI Comprehensive
Active Research Program
53.4
9
NCI Comprehensive
Active Research Program
53.4
10
NCI Comprehensive
Active Research Program
53.4
11
NCI Comprehensive
Active Research Program
53.4
12
NCI Comprehensive
Active Research Program
53.4
13
NCI Comprehensive
Active Research Program
53.4
14
NCI Comprehensive
Active Research Program
53.4
15
NCI Comprehensive
Active Research Program
53.4
1653.4
17
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
53.4
18
NCI Comprehensive
Active Research Program
53.4
19
NCI Comprehensive
Active Research Program
53.4
20
NCI Comprehensive
Active Research Program
53.4
21
NCI Clinical
Active Research Program
53.4
22
NCI Comprehensive
Active Research Program
53.4
23
NCI Comprehensive
Active Research Program
53.4
24
NCI Clinical
Active Research Program
53.4
25
NCI Comprehensive
Active Research Program
53.4
26
Active Research Program
53.4
27
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
53.4
28
NCI Comprehensive
Active Research Program
53.4
29
Active Research Program
53.4
30
Active Research Program
53.4
31
NCI Comprehensive
Active Research Program
53.4
32
NCI Clinical
Active Research Program
53.4
33
NCI Comprehensive
Active Research Program
53.4
34
NCI Comprehensive
Active Research Program
53.4
35
NCI Comprehensive
Active Research Program
53.4
36
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
53.4
37
Active Research Program
53.4
38
NCI Clinical
Active Research Program
53.4
39
NCI Comprehensive
Active Research Program
53.4
40
Active Research Program
53.4
41
Active Research Program
53.4
42
NCI Comprehensive
Active Research Program
53.4
4353.4
44
Active Research Program
53.4
45
Active Research Program
53.4
46
Active Research Program
53.4
47
Active Research Program
53.4
48
Active Research Program
53.4
49
Active Research Program
53.4
50
Active Research Program
53.4
51
Active Research Program
53.4
52
Active Research Program
53.4
5353.4
54
Active Research Program
53.4
55
Active Research Program
53.4
56
BC CancerVancouver, BC
Active Research Program
53.4
57
Active Research Program
53.4
58
Active Research Program
53.4
59
Active Research Program
53.4
6030.9
61
NCI Comprehensive
30.9
62
NCI Comprehensive
30.9
63
NCI Comprehensive
30.9
64
NCI Comprehensive
30.9
6530.9
66
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
30.9
6730.9

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →